Surface Oncology (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 08, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Founding Year
- 2015
- Company Description
- Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.
- Market
- Cancer Immunotherapy
- Location
- Cambridge, MA, USA
- Coinvestors
- Amgen Business Development, Atlas Venture, Elliott Sigal, Novartis Institute for Biomedical Research